Back to the top

Who we are

About Break Through Cancer

Break Through Cancer is dedicated to demonstrating proof-of-concept of a new, collaborative approach to cancer research—helping accelerate research, clinical trials, new treatments, and ideally, cures for the most lethal cancers.

Our Team

Join Our Team

Break Through Cancer is growing our team. We are looking for individuals who are passionate about solving the most intractable problems in cancer research. 

Board of Directors

Dr Bill Nelson Johns Hopkins

William G. (Bill) Nelson, V, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Chairman of the Board, Break Through Cancer; Marion I. Knott Director

Lisa M. DeAngelis, MD

Lisa M. DeAngelis, MD

Memorial Sloan Kettering Cancer Center

Physician-in-Chief and Chief Medical Officer

Giulio F. Draetta, MD, PhD

Giulio F. Draetta, MD, PhD

The University of Texas MD Anderson Cancer Center

Senior Vice President and Chief Scientific Officer

Laurie Glimcher, MD

Laurie Glimcher, MD

Dana-Farber Cancer Institute

President and Chief Executive Officer, Dana-Farber Cancer Institute; Director, Dana-Farber/Harvard Cancer Center

Alice Goodwin

Alice Goodwin

Commonwealth Foundation for Cancer Research

Trustee

William H. Goodwin, Jr

William H. Goodwin, Jr

Commonwealth Foundation for Cancer Research

Trustee

William C. Hahn, MD, PhD

William C. Hahn, MD, PhD

Dana-Farber Cancer Institute; Broad Institute

Executive Vice President and Chief Operating Officer, Dana-Farber Cancer Institute; Institute Member, Broad Institute

Susan Hockfield, PhD

Susan Hockfield, PhD

Massachusetts Institute of Technology

President Emerita

Tyler Jacks, PhD

Tyler Jacks, PhD

Break Through Cancer; Massachusetts Institute of Technology

President, Break Through Cancer; Founding Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Elizabeth M. Jaffee, MD, FAACR, FACP

Elizabeth M. Jaffee, MD, FAACR, FACP

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Cancer Center Deputy Director and Co-Director, Gastrointestinal Cancers Program

David Jaffray, PhD

David Jaffray, PhD

The University of Texas MD Anderson Cancer Center

Senior Vice President, Chief Technology and Digital Officer

David A. Scheinberg, MD, PhD

David A. Scheinberg, MD, PhD

Memorial Sloan Kettering Cancer Center

Chair, Molecular Pharmacology Program and Director, Experimental Therapeutics Center, Memorial Sloan Kettering Cancer Center

John Sherman

John Sherman

Commonwealth Foundation for Cancer Research

Trustee

Matt Vander Heiden, MD, PhD

Koch Institute for Integrative Cancer Research

Trustee, Director, Koch Institute for Integrative Cancer Research, Lester Wolfe (1919), Professor of Molecular Biology Professor of Biology

Scientific Advisory Board

Cory Abate-Shen, PhD

Cory Abate-Shen, PhD

Columbia University

Chair, Department of Molecular Pharmacology and Therapeutics, Vagelos College of Physicians and Surgeons

John D. Carpten, PhD

John D. Carpten, PhD

University of Southern California

Chair, Translational Genomics; Director, Institute of Translational Genomics, Keck School of Medicine

Timothy Cloughesy, MD

Timothy Cloughesy, MD

University of California, Los Angeles

Director, Neuro-Oncology Program; Director, Henry Singleton Brain Cancer Research Program

Benjamin Haibe-Kains, PhD

Benjamin Haibe-Kains, PhD

University of Toronto

Senior Scientist, Princess Margaret Cancer Centre, University Health Network; Associate Professor, Department of Medical Biophysics

Patricia LoRusso, DO

Patricia LoRusso, DO

Yale Cancer Center

Associate Cancer Center Director, Experimental Therapeutics

Frank McCormick, PhD, FRS, DSc (Hon)

Frank McCormick, PhD, FRS, DSc (Hon)

University of California, San Francisco

Professor, Helen Diller Family Comprehensive Cancer Center; Department of Cellular and Molecular Pharmacology

Miriam Merad, MD, PhD

Miriam Merad, MD, PhD

Mount Sinai

Director, Precision Immunology Institute; Director, Mount Sinai Human Immune Monitoring Center, Icahn School of Medicine

Dinah Singer, PhD

Bethesda, MD

Louis M. Staudt, MD, PhD

Bethesda, MD
Alejandro Sweet-Cordero, MD

Alejandro Sweet-Cordero, MD

University of California, San Francisco

Director, Molecular Oncology Initiative, Helen Diller Family Comprehensive Cancer Center

E. John Wherry, PhD

E. John Wherry, PhD

University of Pennsylvania

Chair, Department of Systems Pharmacology and Translational Therapeutics; Director, Institute for Immunology, Perelman School of Medicine

Make a difference

Break Through Cancer was created in February 2021 with an extraordinary matching gift of $250,000,000. Every gift to the Foundation supports groundbreaking cancer research and helps us to meet our matching commitment.

For questions about giving please email LMS@BreakThroughCancer.org